Susan Perlman
Professor, Neurogenetics · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · ·
History
- 1976–1980
Neurodevelopmental Disabilities
Research
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Nature Chemical Biology · 2006 · 348 citations
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
Annals of Neurology · 2021 · 248 citations
Mortality in Friedreich ataxia
Journal of the Neurological Sciences · 2011 · 247 citations
48 papers
47 papers
46 papers
44 papers
35 papers
- JS
33 papers
33 papers
29 papers
Clinical trials
- 2018–2023
Clinical Trial Readiness for SCA1 and SCA3
Principal investigator · Unknown
The Methodist Hospital Research Institute
- 2008–2010
Principal investigator · Completed · Phase 3
Santhera Pharmaceuticals
- 2007–2009
Principal investigator · Completed · Phase 3
Santhera Pharmaceuticals
- 2026–2029
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Site PI · Not yet recruiting · Phase 3
PTC Therapeutics